Schilsky RL - Search Results

1

Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin.

Fleming GF, O'Brien SM, Hoffman PC, Vokes EE, Vogelzang NJ, Schilsky RL, Waggoner SE, Ratain MJ. Fleming GF, et al. Among authors: schilsky rl. Cancer Chemother Pharmacol. 1997;39(3):227-32. doi: 10.1007/s002800050565. Cancer Chemother Pharmacol. 1997. PMID: 8996525 Clinical Trial.

2

Antifolates: the next generation.

Fleming GF, Schilsky RL. Fleming GF, et al. Among authors: schilsky rl. Semin Oncol. 1992 Dec;19(6):707-19. Semin Oncol. 1992. PMID: 1462168 Review.

3

Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer.

Vokes EE, Haraf DJ, Panje WR, Schilsky RL, Weichselbaum RR. Vokes EE, et al. Among authors: schilsky rl. Semin Oncol. 1992 Jun;19(3 Suppl 9):53-8. Semin Oncol. 1992. PMID: 1641658

4

Laboratory and clinical studies of biochemical modulation by hydroxyurea.

Schilsky RL, Ratain MJ, Vokes EE, Vogelzang NJ, Anderson J, Peterson BA. Schilsky RL, et al. Semin Oncol. 1992 Jun;19(3 Suppl 9):84-9. Semin Oncol. 1992. PMID: 1641659 Review.

5

Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.

Vokes EE, Schilsky RL, Weichselbaum RR, Kozloff MF, Panje WR. Vokes EE, et al. Among authors: schilsky rl. J Clin Oncol. 1990 Feb;8(2):241-7. doi: 10.1200/JCO.1990.8.2.241. J Clin Oncol. 1990. PMID: 1688926

6

Phase II study of echinomycin in patients with advanced breast cancer: a report of Cancer and Leukemia Group B protocol 8641.

Schilsky RL, Faraggi D, Korzun A, Vogelzang N, Ellerton J, Wood W, Henderson IC. Schilsky RL, et al. Invest New Drugs. 1991 Aug;9(3):269-72. doi: 10.1007/BF00176982. Invest New Drugs. 1991. PMID: 1783527 Clinical Trial.

7

A phase I study of cisplatin, 5-fluorouracil and leucovorin with escalating doses of hydroxyurea in chemotherapy naive patients.

Vokes EE, Ratain MJ, Janisch L, Hoffman PC, Golomb HM, Schilsky RL. Vokes EE, et al. Among authors: schilsky rl. Eur J Cancer. 1991;27(2):217-8. doi: 10.1016/0277-5379(91)90494-x. Eur J Cancer. 1991. PMID: 1827293 No abstract available.

8

Five-day infusion of fluorodeoxyuridine with high-dose oral leucovorin: a phase I study.

Vokes EE, Raschko JW, Vogelzang NJ, Warfield EE, Ratain MJ, Doroshow JH, Schilsky RL. Vokes EE, et al. Among authors: schilsky rl. Cancer Chemother Pharmacol. 1991;28(1):69-73. doi: 10.1007/BF00684960. Cancer Chemother Pharmacol. 1991. PMID: 1828191 Clinical Trial.

9

Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the Cancer and Leukemia Group B.

Oster MW, Schilsky RL, Faraggi D, Korzun AH, Perry M, Moore A, Kalra J, Wood WC, Henderson IC. Oster MW, et al. Among authors: schilsky rl. Cancer. 1991 Oct 15;68(8):1696-8. doi: 10.1002/1097-0142(19911015)68:8<1696::aid-cncr2820680807>3.0.co;2-b. Cancer. 1991. PMID: 1913511 Clinical Trial.

10

Paradoxical relationship between acetylator phenotype and amonafide toxicity.

Ratain MJ, Mick R, Berezin F, Janisch L, Schilsky RL, Williams SF, Smiddy J. Ratain MJ, et al. Among authors: schilsky rl. Clin Pharmacol Ther. 1991 Nov;50(5 Pt 1):573-9. doi: 10.1038/clpt.1991.183. Clin Pharmacol Ther. 1991. PMID: 1934870

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

381 results

Search Page

Filters